Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 21;9(9):680.
doi: 10.3390/pathogens9090680.

Survival of Lassa Virus in Blood and Tissue Culture Media and in a Small Particle Aerosol

Affiliations

Survival of Lassa Virus in Blood and Tissue Culture Media and in a Small Particle Aerosol

Sophie J Smither et al. Pathogens. .

Abstract

Knowledge of the survival and stability of a pathogen is important for understanding its risk, reducing its transmission, and establishing control measures. Lassa virus is endemic in West Africa, causes severe disease, and is an emerging pathogen of concern. Our study examined the survival of Lassa virus in blood and tissue culture media at two different temperatures. The stability of Lassa virus held within a small particle aerosol was also measured. In liquids, Lassa virus was found to decay more quickly at 30 °C compared to room temperature. Sealed samples protected from environmental desiccation were more stable than samples open to the environment. In a small particle aerosol, the decay rate of Lassa virus was determined at 2.69% per minute. This information can contribute to risk assessments and inform mitigation strategies in the event of an outbreak of Lassa virus.

Keywords: Lassa virus; aerosol; blood; stability; survival; tissue culture media.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Titre of Lassa virus in blood or tissue culture media over time. The persistence of Lassa virus in blood (top row, (A,B)) or tissue culture media, TCM, (bottom row, (C,D)) was measured over two days. Samples were stored at room temperature (RT, 19–22 °C, left, (A,C)) or 30 °C (right, (B,D)), open to the external environment (white circles) or sealed (black triangles). Experiments were performed on two separate occasions and the individual titres from three replicates per experiment are shown (n = 6 per condition). The limit of detection (LoD) of the TCID50 assays is shown as a dotted line on each graph.
Figure 2
Figure 2
Aerosol survival of Lassa virus. (Left) Lassa virus was aerosolised in tissue culture media and held in a Goldberg Drum at medium relative humidity (50–60%). Impinger samples were taken at set time points and enumerated by TCID50 assay. Three aerosol experiments were performed: each time-point was assayed in triplicate. Counts were adjusted for dilution effect of sampling and mean adjusted counts of each of the 3 experiments plus a best fit line are shown. The limit of detection (LoD) of the TCID50 assays is shown as a dotted line. (Right) The theoretical decay of Lassa virus in TCM with decay as a percentage of starting amount shown. Horizontal lines at 50% represent half-life and at 10% give an indication of time for starting amount to drop by 90% (1× Log10).

References

    1. Asogun D.A., Günther S., Akpede G.O., Ihekweazu C., Zumla A. Lassa fever: Epidemiology, clinical features, diagnosis, management and prevention. Infect. Dis. Clin. N. Am. 2019;33:933–951. doi: 10.1016/j.idc.2019.08.002. - DOI - PubMed
    1. Delahoy M.J., Wodnik B., McAliley L., Penakalapati G., Swarthout J., Freeman M.C., Levy K. Pathogens transmitted in animal feces in low- and middle-income countries. Int. J. Hyg. Environ. Health. 2018;221:661–676. doi: 10.1016/j.ijheh.2018.03.005. - DOI - PMC - PubMed
    1. Monath T.P. A short history of Lassa fever: The first 10–15 years after discovery. Curr. Opin. Virol. 2019;37:77–83. doi: 10.1016/j.coviro.2019.06.005. - DOI - PubMed
    1. WHO Essential medicines and health products. [(accessed on 8 July 2020)]; Available online: https://www.who.int/medicines/ebola-treatment/WHO-list-of-top-emerging-d...
    1. WHO Emergencies Preparedness, Response. Lassa Fever. [(accessed on 8 July 2020)]; Available online: https://www.who.int/csr/don/20-april-2018-lassa-fever-nigeria/en/

Grants and funding

LinkOut - more resources